For effective implementation of the Pharmaceutical Quality System, more than mere procedures and documents is required. Leadership accountability of the pharmaceutical quality system requires management not only to be in charge of quality but also to make investments in its success. The 2026 leaders should integrate ICH Q10 principles into the framework of digital and data-based leadership.
Senior Management Responsibilities Under ICH Q10
Responsibilities of management ICH Q10 PQS entail having an established quality policy, allocating sufficient resources, assigning responsibilities, and communication of quality expectations within the organization. The management should make sure that the quality goals are aligned with the business objectives without compromising the quality of the products or patient’s safety.
Moving Beyond the Written Quality Policy
Quality policies have little value if the leader’s commitment stops at simply endorsing the document. The person leading must be able to show his/her dedication by performing quality reviews, participating in investigations, making decisions on time, and interacting with quality teams. Employees need to be motivated to report any quality issues as well.
Real-Time Quality Oversight Through Digital Tools
Digital systems can offer managers relevant information regarding deviations, CAPAs, complaints, and processes. Use of dashboards can help to spot key trends and enable the leadership to realize potential risks before they arise.
Effective Quality policy and real-time oversight pharma requires management to use this information for informed decisions. AI and analytics can further support trend detection and risk prioritisation when appropriately governed.
Setting Realistic Zero-Deviation Goals
Zero-deviation goals for quality in the pharmaceutical industry can promote prevention, but managers must be wary of setting goals that would discourage reporting. The objective is to reduce preventable deviations, recurring problems, and variability without compromising the reporting environment.
A good leader needs to have the right balance between quality goals and other factors like speed, cost, etc.
Building Accountability and Continuous Improvement
manage activities outsourced, evaluate the supplier’s performance, allocate adequate resources, train employees, and assess recurrent quality risks.
While performing regulatory inspections, senior management needs to show an understanding of significant quality risks, performance of the PQS, the efficacy of CAPAs, and the focus areas for improvement. The quality responsibility is thus demonstrated through ownership and data-driven decision making.
Conclusion
Good leadership converts the PQS from a reactive system to a proactive one. This is achieved through accountability, immediate supervision, practical quality goals, and continual improvement. This will help the leadership improve the quality culture, minimize risks, and ensure quality products.
Frequently Asked Questions
- What are the key responsibilities of senior leadership under ICH Q10 for the Pharmaceutical Quality System?
Such activities involve setting up the quality policy, resource provision, responsibilities, expectations, and assessment of the performance of the PQS.
- How can senior management move from written quality policy to active, real-time oversight of the PQS?
Quality dashboards, management review, data analysis and communications will be used as quality control tools.
- Is a zero-deviation goal realistic in pharmaceutical manufacturing, and how should leaders approach it?
The leaders should use it as an objective in order to prevent demotivating deviation reporting.
- What role does leadership play in enabling digital tools and AI for better quality oversight?
Leaders offer resources, leadership and accountability in the right use of technology and artificial intelligence.
- How should senior leaders demonstrate accountability for quality during regulatory inspections?
They have to be knowledgeable about quality risks that are very critical; carry out an analysis of PQS; and continuously improve their CAPA.
